I don't know how much it costs to produce the e2 collector. My suggestion about the cost being higher than the traffic will bear is based upon the calculation that SAMNOTSAMUEL made using the expected revenue and expected market. IMO if the cost to manufacture is $0.25, and the sale price is $5, they are out of their greedy minds. If the expected sale price is $1, then that makes a lot more sense. I think the problem with this discussion is that none of us have the numbers to accurately calculate the cost, and we don't know the expected sale price, let alone what the market will bear.
You are right that there are cost savings to insurance companies if more accurate collection allows less follow-up or prevents false negatives, where the woman will need expensive surgery down the road. I don't know how CYCR would go about showing that there are fewer false negatives using their collection since any study would take a long time, years not months, to show that women whose sample is collected with the e2 have fewer cancers a year or two later.
I am just a small investor trying to get a handle on the company's plan to be profitable in the near term. I know that people within the company are surely asking and answering these same questions. I am only questioning because I don't know, and a good deal of what I see here is more hopeful speculation than real calculation based upon information. But then again maybe the company doesn't want to share that information at this time.
News 
Market Data 
Discover 
